Chart calendar Synaptogenix, Inc.
Upcoming events on Synaptogenix, Inc.
No events available
Past events on Synaptogenix, Inc.
20/12/2023 16:00 | Annual General Meeting |
06/12/2023 | IABS Forum |
14/04/2023 16:00 | Extraordinary Shareholders Meeting |
16/02/2023 16:00 | Extraordinary Shareholders Meeting |
26/10/2022 17:00 | ThinkEquity Conference |
10/10/2022 | Annual General Meeting |
26/07/2022 21:30 | Corporate Update Call |
16/05/2022 | Cell Symposium |
29/03/2022 19:00 | Hanson Wade Neurodegenerative Drug Development Summit |
15/03/2022 07:00 | Alzheimer and Parkinson Diseases International Conference |
29/09/2021 19:40 | Benzinga Healthcare Small Cap Conference |
13/09/2021 12:00 | H.C. Wainwright Global Investment Conference |
26/07/2021 21:15 | Alzheimers Association International Conference |
28/04/2021 17:40 | Sachs Neuroscience Innovation Forum |
06/04/2021 | Extraordinary Shareholders Meeting |
14/03/2021 14:00 | Alzheimer and Parkinson Diseases International Conference |
09/03/2021 12:00 | H.C. Wainwright Global Life Science Conference |
17/02/2021 16:30 | MicroCap Rodeo Winter Wonderland Conference |
15/12/2020 21:15 | Business Update Call |
Annual results
Fiscal Period | December | 2021 | 2022 |
---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | 0,00 | -16,1 -13,4 -20.01% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -5,57 -13,3 57.95% |
Net income Million USD | Released Forecast Spread | -12,6 | -5,69 -13,3 57.07% |
EPS USD | Released Forecast Spread | -62,8 | -20,3 -47,3 57.14% |
Announcement Date | 29/03/22 | 21/03/23 |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -3,28 -3,15 -4.21% | -3,80 -3,32 -14.52% | -3,17 -3,83 17.39% | -5,89 -3,20 -84.08% | -2,92 -3,91 25.29% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,28 -3,15 -4.06% | -3,75 -3,32 -13.18% | -3,03 -3,83 21.06% | 4,48 -3,20 240.12% | -1,71 -3,91 56.23% |
Net income Million USD | Released Forecast Spread | -3,28 -3,15 -4.06% | -3,75 -3,32 -13.18% | -3,03 -3,83 21.06% | 4,37 -3,20 236.49% | -1,98 -3,91 49.43% |
EPS USD | Released Forecast Spread | -11,8 -12,8 7.84% | -13,5 -12,0 -12.5% | -10,8 -13,8 21.82% | 15,8 -11,5 236.96% | -6,50 -14,0 53.57% |
Announcement Date | 13/05/22 | 05/08/22 | 10/11/22 | 21/03/23 | 15/05/23 |
30/06/2024 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Synaptogenix, Inc.
23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
14/05/2024 21:05 | NUVATION BIO INC.: Q1 2024 Earnings Release |
14/05/2024 12:30 | ABSCI CORPORATION: Q1 2024 Earnings Release |